TOP CATEGORY: Chemicals & Materials | Life Sciences | Banking & Finance | ICT Media
Click for best price
Zinc-finger nucleases (ZFNs) are artificial restriction enzymes generated by fusing a zinc finger DNA-binding domain to a DNA-cleavage domain. Zinc finger domains can be engineered to target specific desired DNA sequences and this enables zinc-finger nucleases to target unique sequences within complex genomes. By taking advantage of endogenous DNA repair machinery, these reagents can be used to precisely alter the genomes of higher organisms. Alongside CRISPR/Cas9 and TALEN, ZFN is a prominent tool in the field of genome editing.
This report contains market size and forecasts of Zinc Finger Nuclease Technology in Global, including the following market information:
Global Zinc Finger Nuclease Technology Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Zinc Finger Nuclease Technology market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Cell Line Engineering Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Zinc Finger Nuclease Technology include Sigma-Aldrich, Sangamo Therapeutics, Labomics, Thermo Fisher Scientific and Gilead, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Zinc Finger Nuclease Technology companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Zinc Finger Nuclease Technology Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Zinc Finger Nuclease Technology Market Segment Percentages, by Type, 2021 (%)
Cell Line Engineering
Animal Genetic Engineering
Plant Genetic Engineering
Other
Global Zinc Finger Nuclease Technology Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Zinc Finger Nuclease Technology Market Segment Percentages, by Application, 2021 (%)
Biotechnology Companies
Pharmaceutical Companies
Hospital Laboratory and Diagnostic Laboratory
Academic and Research Institutes
Others
Global Zinc Finger Nuclease Technology Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Zinc Finger Nuclease Technology Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Zinc Finger Nuclease Technology revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Zinc Finger Nuclease Technology revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Sigma-Aldrich
Sangamo Therapeutics
Labomics
Thermo Fisher Scientific
Gilead
| Report Attributes | Report Details |
|---|---|
| Report Title | Zinc Finger Nuclease Technology Market, Global Outlook and Forecast 2022-2028 |
| Historical Year | 2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year | 2021 |
| Forecast Year | 2029 |
| Number of Pages | 69 Pages |
| Customization Available | Yes, the report can be customized as per your need. |
Frequently Asked Questions ?
